PROC
Clinical trials for PROC explained in plain language.
Never miss a new study
Get alerted when new PROC trials appear
Sign up with your email to follow new studies for PROC, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New hope for Tough-to-Treat cancers: first human trial of targeted therapy begins
Disease control Recruiting nowThis is the first human study of HWK-016, a new targeted cancer drug designed to deliver chemotherapy directly to cancer cells. The trial will enroll 265 adults with advanced ovarian or endometrial cancers that have stopped responding to standard treatments. Researchers will test…
Matched conditions: PROC
Phase: PHASE1 • Sponsor: Whitehawk Therapeutics, Inc. • Aim: Disease control
Last updated Apr 02, 2026 14:57 UTC
-
New targeted cancer drug enters first human trials for Tough-to-Treat tumors
Disease control Recruiting nowThis is the first human study of a new experimental cancer drug called HWK-007. Researchers are testing it in adults with advanced ovarian, endometrial, or non-small cell lung cancers that have stopped responding to standard treatments. The main goals are to find the safest dose …
Matched conditions: PROC
Phase: PHASE1 • Sponsor: Whitehawk Therapeutics, Inc. • Aim: Disease control
Last updated Mar 30, 2026 14:33 UTC